Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking strategy to diabetes management. These innovative medications function by mimicking the inherent actions of GLP-1, a hormone secreted by the https://ilovebookmark.com/story20644214/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes